The Global Cancer Drug market represents its costing, production, scope to increase its demand by 2018 - 2023 year. The Cancer Drug Market Report is based on Global key findings, Regional analysis, Growth factors and others. The Report helps to fasten the business across the globe and provides in-depth information.
Global Cancer Drug Market was valued at USD 73.41 Billion in the year 2017. Global Cancer Drug market is further estimated to grow at a CAGR of 7.98% from 2018 to 2023 to reach USD 116.39 Billion by the year 2023.
North America region holds the highest market share in 2017 with APAC region is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the biggest market in 2017 and it is projected to grow at a gradual pace in the coming years.
Roche Diagnostics (Switzerland), Celgene (U.S), Johnson & Johnson (U.S) and Novartis (Switzerland) are some of the key manufacturers in the Global Blood Screening market. From all the key players Roche Diagnostics holds the substantial market share because of its better global presence both at production and at an operational level.
Rising research and development expenses to cater changing demand of end users, similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
Growing incidence and pervasiveness of various types of cancer
Academic alliances and partnerships
Side-effects of anti-cancer drug therapy
The high cost of drug development and a threat of failure
Scientific advancements in treatment methods
Increasing focus on personalized Anti-cancer medicine
The Immunotherapy segment in the global Cancer Drug Market is expected to hold the highest market share during the forecast period. The growth can be attributed to growing areas within oncology R&D, high efficacy and fewer side effects and unique molecular level targeting.
On the other hand, Blood Cancer by the application is expected to grow at the highest CAGR during the year 2018-2023. Majorly due to growing number of blood cancer patient and the high cost of drugs used for the treatment of blood cancer.
Key Benefits for Stakeholders
Cancer Drug Manufacturers, Distributors and Retailers
Research and Consulting organization
Technology Standards Organizations, Forums, Alliances and Associations
Regulatory bodies, policy actors, and consumers.
By Products & Services
Immunotherapy (biologics therapy)
Other types of cancers
Key Market Players
- 1. Roche Holdings Inc.
- 2. Johnson & Johnson
- 3. Novartis AG
- 4. Celgene
- 5. Eli Lilly and Company
- 6. Pfizer
- 7. Celgene Corporation
- 8. Sanofi
- 9. Merck & Co.
- 10. Amgen Inc.
Read Report Overview with Full TOC at goo.gl/8rokE7
Category: Market Research Publishers and RetailersCompany about: Genesis Market Insights (GMI), is a subsidiary of Genesis Management & Market Research Pvt.Ltd. (GMMR) having a strong experience both in primary and secondary market research serving small to large scale enterprises across the globe. Established in 1993, GMMR has become a recommended brand for Market Research for various international and MNC Corporations with its strong data foundation. With its exhaustive research capabilities, strong analytics services and in-house data validation tools, ...
For more information:Make an Inquiry about this report HERE!